Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Layal Liverpool, a 3rd year Infection, Immunology & Translational Medicine DPhil student at St Edmund Hall, has been awarded a prestigious British Science Association (BSA) media fellowship, funded by the Society for Applied Microbiology.

Layal in the lab

Layal’s DPhil research, based in the lab of Prof. Jan Rehwinkel at the MRC Weatherall Institute of Molecular Medicine, focuses on investigating how invading viruses are detected by the body’s immune system. Talking about her research interests, Layal said “I am fascinated by viruses because they are relatively simple and yet are capable of causing such complex and devastating diseases.”

Alongside her DPhil studies, Layal is also a passionate science communicator and is frequently involved in public engagement activities. In 2016, her short talks on HIV and flu landed her in the regional final of the science communication competition Fame Lab UK. In Layal’s own words “I believe that engaging the public with the research that we do is an important part of our job as scientists. The media provides a powerful public engagement tool because it enables a large and diverse audience to be reached.”

The BSA media fellowship funds scientists to spend 2-6 weeks working at a well-known media outlet during the summer of 2018. BSA Media Fellows are mentored by professional journalists and learn how the media operates and reports on science, how to communicate with the media and to engage the wider public with science through the media.

Following their media placement, Fellows attend the British Science Festival in September, where they have the opportunity to gain valuable experience working in the BSA Press Centre alongside a range of media organisations from all over the UK.

In response to being awarded the fellowship, Layal said “I am absolutely delighted and extremely grateful for this fantastic opportunity!"

Similar stories

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

World’s largest clinical trial for COVID-19 treatments expands internationally

Clinical Trials Coronavirus COVID-19 General

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.

Reprogramming tumour cells using an antimalarial drug

General Research

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.